Genflow Biosciences plc (LON:GENF – Get Free Report) traded up 2.7% on Wednesday . The company traded as high as GBX 2.14 and last traded at GBX 1.90. 6,361,326 shares changed hands during trading, an increase of 92% from the average session volume of 3,310,278 shares. The stock had previously closed at GBX 1.85.
Genflow Biosciences Price Performance
The firm’s fifty day moving average is GBX 1.91 and its two-hundred day moving average is GBX 1.65. The firm has a market cap of £10.21 million, a price-to-earnings ratio of -4.12 and a beta of 2.37.
About Genflow Biosciences
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Further Reading
- Five stocks we like better than Genflow Biosciences
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
